Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Latest Articles

  • You have access
    Time to change: A systems pharmacology approach to disentangle mechanisms of drug-induced mitochondrial toxicity
    Charlotte A. Hoogstraten, Jonathan J. Lyon, Jan A.M. Smeitink, Frans G.M. Russel and Tom J.J. Schirris
    Pharmacological Reviews February 17, 2023, PHARMREV-AR-2022-000568; DOI: https://doi.org/10.1124/pharmrev.122.000568
  • You have access
    ADVANCES IN NANOZYMES AS A PARADIGM FOR VIRAL DIAGNOSTICS AND THERAPY
    Garima Sharma, Srijan Chatterjee, Chiranjib Chakraborty and Jin-Chul Kim
    Pharmacological Reviews February 17, 2023, PHARMREV-AR-2022-000719; DOI: https://doi.org/10.1124/pharmrev.122.000719
  • You have access
    Sulfotransferase 2B1b, Sterol Sulfonation, and Disease
    Ian Cook and Thomas S. Leyh
    Pharmacological Reviews February 17, 2023, PHARMREV-AR-2022-000679; DOI: https://doi.org/10.1124/pharmrev.122.000679
  • You have access
    Cellular senescence: from mechanisms to current biomarkers and senotherapies
    Vasco Lucas, Cláudia Cavadas and Célia Alexandra Aveleira
    Pharmacological Reviews February 17, 2023, PHARMREV-AR-2022-000622; DOI: https://doi.org/10.1124/pharmrev.122.000622
  • Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect
    You have access
    Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect
    Eleanor Blair Towers, Ivy L. Williams, Emaan I. Qillawala, Emilie F. Rissman and Wendy J. Lynch
    Michael Nader, ASSOCIATE EDITOR
    Pharmacological Reviews March 2023, 75 (2) 217-249; DOI: https://doi.org/10.1124/pharmrev.121.000361
  • You have access
    Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications
    Hedieh Shahpasand-Kroner, Ibrar Siddique, Ravinder Malik, Gabriel R. Linares, Magdalena I. Ivanova, Justin Ichida, Tatjana Weil, Jan Münch, Elsa Sanchez-Garcia, Frank-Gerrit Klärner, Thomas Schrader and Gal Bitan
    Habibeh Khoshbouei, ASSOCIATE EDITOR
    Pharmacological Reviews March 2023, 75 (2) 263-308; DOI: https://doi.org/10.1124/pharmrev.122.000654
  • Open Access
    Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood
    Fulton T. Crews, Leon G. Coleman, Victoria A. Macht and Ryan P. Vetreno
    Robert Dantzer, ASSOCIATE EDITOR
    Pharmacological Reviews March 2023, 75 (2) 380-396; DOI: https://doi.org/10.1124/pharmrev.122.000710
  • Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
    You have access
    Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
    Edris Choupani, Mohammad Mahmoudi Gomari, Saeed Zanganeh, Sherko Nasseri, Kaveh Haji-allahverdipoor, Neda Rostami, Yaeren Hernandez, Safa Najafi, Neda Saraygord-Afshari and Arshad Hosseini
    Michael Gottesman, ASSOCIATE EDITOR
    Pharmacological Reviews March 2023, 75 (2) 309-327; DOI: https://doi.org/10.1124/pharmrev.122.000665
  • Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease
    You have access
    Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease
    Kristan H. Cleveland and Rick G. Schnellmann
    John Schuetz, ASSOCIATE EDITOR
    Pharmacological Reviews March 2023, 75 (2) 250-262; DOI: https://doi.org/10.1124/pharmrev.122.000560
  • Open Access
    Dopamine, Immunity, and Disease
    Breana Channer, Stephanie M. Matt, Emily A. Nickoloff-Bybel, Vasiliki Pappa, Yash Agarwal, Jason Wickman and Peter J. Gaskill
    Habibeh Khoshbouei, ASSOCIATE EDITOR
    Pharmacological Reviews January 2023, 75 (1) 62-158; DOI: https://doi.org/10.1124/pharmrev.122.000618

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 154
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics